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Abstract 
Mesenchymal hamartoma of the liver (MHL) is a rare benign lesion occurring primarily in 
the pediatric population. While the precise pathogenesis of the tumor is not certain, the 
most common theory relates to aberrant mesenchyme development in the portal tract 
likely related to the bile ducts. A 53-year-old female was evaluated for an incidental liver 
mass. Initial CT scan showed a cystic lesion in the right lobe of the liver and follow-up 
imaging revealed an increase in size and the percent solid component within the mass. 
In view of these changes, a nondiagnostic biopsy was obtained followed by extirpation 
of the lesion. Gross pathological review of the lesion identified a 9 × 9 × 7.5 cm, 
pink-yellow-tan, gelatinous mass, with a >1 cm clear surgical margin. Histologically, the 
mass consisted of benign dilated bile ducts, as well as myxoid stroma with spindle cells 
showing smooth muscle differentiation. The patient was discharged home on 
postoperative day five. A review of the literature for MHL in adults reports 30 previous 
cases, predominantly published as individual case reports describing the size, lobe(s) of 
the liver affected, and the cystic/solid nature of the tumor. MHL in adults may represent a 
potentially premalignant lesion, as the emerging literature supports a potential 
relationship between MHL and malignant undifferentiated embryonal sarcoma in regards 
to cytogenetic analysis. Aggressive surgical management of MHL in adults is mandated 
when feasible. 
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Introduction 
Mesenchymal hamartoma of the liver (MHL) is a benign lesion that classically presents 
as an enlarging abdominal mass in children before the age of two. Maresch initially 
described the tumor in 1903, but the term MHL was first used by Edmondson in 1956 [1]. 
MHL may affect either lobe of the liver and presents as a cystic or solid mass, and on 
occasion both components may be present. Alkaline phosphatase, β-human chorionic 
gonadotropin, serum transaminases and α-fetoprotein are usually within normal limits in 
patients with MHL. Hematoxylin and eosin staining as well as immunohistochemical 
studies [2, 3] have described MHL as having spindle cells positive for vimentin and 
smooth muscle actin and negative for CD31, CD34 and S100 proteins, while the ducts 
stain positive for cytokeratin 7 and negative for cytokeratin 20. Even though the exact 
pathogenesis of MHL is largely unknown, the most common theory is that it represents 
aberrant primitive mesenchyme development in the portal tract likely relating to the bile 
ducts.  
Case Report 
A 53-year-old white female presented in January 2007 with colicky abdominal pain secondary to 
ureteral stones; subsequent abdominal ultrasound imaging and a CT scan of the abdomen demonstrated 
an incidental liver mass (fig. 1). This lesion was initially thought to be a hemangioma, however 
follow-up imaging demonstrated an increase in the size of the mass, notably the solid component. This 
change in size as well as the characteristics of the mass prompted percutaneous biopsy in May 2008, 
which was nondiagnostic. The patient was referred for a hepatobiliary surgical consult. The patient’s 
past surgical history was noncontributory, consisting of cyst removal of the left breast at the age of 16, a 
partial thyroidectomy in 2001 and a total abdominal hysterectomy with partial oophorectomy in 2006. 
The preoperative work-up included a CEA level of <0.5 ng/ml, an α-fetoprotein level of 3.6 ng/ml, a 
CA 19-9 level of 17 U/ml, a negative hepatitis panel, a total bilirubin level of 0.3 mg/dl, an alkaline 
phosphatase level of 87 U/l, an aspartate transaminase level of 45 U/l and an alanine transaminase level 
of 50 U/l. Repeat abdominal CT scan (fig. 2) revealed an enlarging heterogeneous, progressively 
enhancing solid and cystic mass in the anterior segment of the right hepatic lobe (Couinaud’s 
segments V and VIII). The mass measured 8.9 × 8.7 × 7.5 cm and displaced hepatic and portal veins. As 
a result of the increasing size of this partially cystic and solid liver mass over the course of 18 months, 
surgical excision of the mass was recommended. 
In July 2008, the patient underwent a right trisegmentectomy and cholecystectomy. The pathological 
report identified a 19 × 17 × 11 cm resected hepatic lobe weighing 1,006 g, with a 9 × 9 × 7.5 cm, 
well-circumscribed, pink-yellow-tan, gelatinous mass, with a 1 cm clear surgical margin. The mass was 
cystic in the central portion and contained 30 ml of clear, yellowish fluid. Histologically, the mass 
consisted of rare benign dilated bile ducts (fig. 3) corresponding to the cystic areas noted grossly, as well 
as myxoid stroma with spindle cells showing smooth muscle differentiation confirmed by positive 
staining for vimentin, smooth muscle actin and desmin. The mass’ fibrous capsule showed bile duct 
proliferation at the edge with a sharp transition to normal liver parenchyma. CD34 and hormone 
receptor studies were negative, thus excluding solitary fibrous tumor and angiomyxoma. The patient’s 
hospital course was uneventful and she was discharged home on postoperative day five. 
Discussion 
MHL is a benign lesion of the liver representing the second most common pediatric 
liver tumor (after hepatoblastoma) and constitutes 8% of all pediatric tumors. Eighty 
percent of the lesions are found by the age of two and the remainder are identified by five 
years of age with the male to female ratio being 2:1 [2]. Intrauterine MHL cases have been 
documented in several reports. Laberge et al. [4] reviewed twelve cases with eight fetuses 
surviving to term after being diagnosed ultrasonographically in the third trimester.  
Case Rep Gastroenterol 2010;4:84–92 
DOI: 10.1159/000260183 
Published online: March 13, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
86
Tumor resection in these eight cases occurred in the first three months of life. In the four 
lethal intrauterine MHL cases, Laberge et al. attributed the fetal demise to mass effects of 
the tumor causing compression of the heart, kidneys and umbilical veins [4]. Although 
the majority of MHL cases reported are in the pediatric population, 30 cases have been 
reported in the English and Japanese language literature in adults ranging in age from 19 
to 69 years (table 1) [5–7]. Of these 30 cases, 22 (73%) have been reported in females and 
only 8 (27%) in males, with an average age of 40 and 57, respectively. Thus, males are 
more often affected in the pediatric population while females are more often affected in 
the adult population. 
The clinical presentation of MHL appears to depend on the age of the patient. Most 
pediatric patients present with painless abdominal enlargement normally appreciated by 
the parent. If the mass becomes significantly large or liver function becomes 
compromised, ascites and jaundice may ensue. In severe cases there may be compression 
of the diaphragm and lungs causing respiratory difficulties. Although the adult case 
presented here was asymptomatic, Cook et al. [2] reported on eight adult cases, seven of 
whom were symptomatic, with the presenting complaint being diffuse abdominal pain. In 
agreement with Cook et al., a retrospective analysis of 17 cases by Yesim et al. [8] report 
that 10 cases were symptomatic. In addition to diffuse abdominal pain, reported 
symptoms and signs include hepatomegaly, right hypochondriac pain and left upper 
quadrant pain. 
Radiographic appearance of MHL represents a continuum from predominantly cystic 
to mostly solid tumors. In pediatric patients the literature is unclear in regards to the 
cystic or solid nature of MHL. Early studies by Stocker and Ishak [9] describe nearly all 
pediatric cases as having cysts, however Chau et al. [10] reported that children more 
commonly have solid lesions. Interestingly, Chau et al. have also reported that adults have 
predominantly cystic lesions [10] while Hernandez et al. [5] have published that both 
pediatric and adult cases are primarily cystic. In the adult population, when solely cystic 
or solid tumors are present, females were more likely to have a cystic tumor, while males 
showed no predilection. When both cystic and solid portions of MHL were encountered, 
females were predominantly affected. 
Location of the tumor in the liver appears to be different between pediatric and adult 
patients. MHL in children is primarily localized to the right lobe [10], while in adults, 
12 cases (40%) were localized to the left lobe, 12 (40%) to the right lobe and in 6 (20%) 
tumors crossed into both lobes. Interestingly, adult males have a predilection for the right 
lobe of the liver, while females primarily have MHL in the left lobe. In situations when 
MHL was found in both lobes, females were more commonly affected than males. 
Ultrasonography is typically the initial evaluation technique for suspected hepatic 
masses since it is readily accessible, can quickly delineate the cystic or solid nature of the 
lesion, and provides an estimate of mass size. CT imaging and/or MRI typically follow 
ultrasonography, particularly in preparation for surgical resection of the tumor. 
Ultrasonographic images of MHL show anechoic cystic regions with intervening thin 
septations, and axial imaging is helpful to further demonstrate the cystic or solid nature of 
MHL [11]. On contrast-enhanced CT the solid component of MHL will enhance while 
the cystic portion will not [11]. MRI shows a characteristic low signal intensity on 
T1-weighted images and high intensity imaging on T2-weighted imaging [12] (table 2). 
Even though multiple radiographic imaging techniques may be employed in the 
evaluation of a hepatic mass, imaging results for MHL are nonspecific. The differential 
diagnosis for predominantly cystic lesions includes: simple hepatic cyst, hydatid cyst,  
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subcapsular pseudocyst, biliary cystadenocarcinoma, and cystic metastasis. Mortele and 
Ros [13] depict the radiographic nature of a variety of cystic liver lesions, particularly 
noting CT and MRI subtleties that may be helpful in diagnosis. In the case of a solid 
lesion, focal nodular hyperplasia, hepatic adenoma, cavernous hemangioma, 
angiomyolipoma, solitary hamartoma, and hepatocellular carcinoma are among the more 
common lesions to consider. A solid MHL may present as a hypovascularized lesion on 
angiography [13], but this is a nonspecific finding and not helpful in differentiating from 
the aforementioned lesions. In the present case fine needle biopsy did not reveal a 
definitive diagnosis, necessitating surgical excision of the lesion. 
Recent cytogenetic studies have shown MHL to involve rearrangements at 
chromosome 19. Analysis of eight MHL cases revealed the following genetic 
abnormalities: three involving t(11;19)(q13;q13.4), and single cases of t(11;19)(q13;q13.3), 
t(15;19)(q15;q13.4), a rearrangement of 11q2, 17q11 and 19q13.3, del(19)(q13.1q13.4) 
and t(11;19)(q11;q13.4) [14]. A significant finding is the similar genetic profile MHL 
shares with undifferentiated embryonal sarcoma (UES). UES is a rare pediatric 
malignancy composed of a sarcomatous mesenchymal component, as well as having 
hypercellular stroma, nuclear pleomorphism and mitotic activity, interspersed with 
benign branching ductal structures [3]. Over the past few years a number of cases of UES 
have developed within MHL, displaying similar genetic rearrangements in the region of 
19q13.4 [3, 15, 16]. These include two cases of (19)(q13.4) and one case showing t(11;19) 
(q11;q13.3–13.4), nearly identical to genetic rearrangements seen in previous solitary 
cases of MHL [16]. Rajaram et al. [14] have postulated that the t(11;19) translocation is 
likely related to the development of solitary cases of MHL, but for progression of MHL to 
UES additional genetic alterations at other loci are required.  
In addition to cytogenetic similarities, histological resemblance provides a potential 
link for progression from a benign MHL lesion to malignant UES. In cases described by 
Lauwers et al. [3] and Begueret et al. [15], UES regions were separated from MHL areas by 
transitional zones containing a histological mixture of the two entities. On further 
analysis, similar immunohistochemical characteristics and DNA ploidy of the three zones 
led Begueret et al. to conclude a coexistence of a well-differentiated phenotype (MHL) 
and a sarcomatous region (UES), separated by a zone containing a mixture of the two 
entities [15]. 
Hepatic angiosarcoma is the most common primary sarcoma of the liver and a solo 
case was recently reported to arise from an adult MHL [6]. Although hepatic 
angiosarcoma is usually associated with thorotrast, vinyl chloride and arsenic exposure, Li 
et al. [6] report a case of a woman with no prior carcinogen exposure presenting with an 
angiosarcoma arising from an untreated, previously diagnosed MHL. Though not direct 
evidence of MHL malignant transformation to angiosarcoma, the premalignant potential 
of MHL should be expanded to include UES and angiosarcoma, particularly when MHL is 
encountered in adult patients. 
Although less invasive laparoscopic techniques are desirable, anatomic or 
nonanatomic resection with a negative margin is the standard treatment. The potential 
for massive tumor growth and possible degeneration to UES and/or angiosarcoma 
provides additional support against cautious clinical monitoring if the patient is a 
reasonable surgical candidate. Enlarging solid or cystic neoplasms of the liver that cannot 
be accurately diagnosed with radiographic imaging and histology should be considered 
for en bloc surgical resection with negative surgical margins.  
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Conclusion 
MHL in adults is a rare and potentially premalignant lesion that presents as a 
solid/cystic neoplasm. Symptoms are typically nonspecific, though abdominal pain is the 
most common. Laboratory results are noncontributory and radiographic imaging is 
variable and inconclusive. Needle biopsy is rarely diagnostic and surgical excision of 
symptomatic or enlarging lesions is recommended to exclude the possibility of 
malignancy and to establish a further diagnosis. The emerging literature suggests a 
relationship between MHL and UES in regards to histological similarities and cytogenetic 
analysis, and supports a recommendation for aggressive surgical management when 
feasible. 
 
 
 
Table 1. Cases of adult MHL 
Number  Reference  Age  Gender  Liver lobe  Size  Gross  
appearance 
01  Yamamura [17]  22  F  both  not described  cystic 
02  Grases [18]  19  F  left  24×19×8 cm  cystic 
03 Dooley  [19]  21  F  right  26×20×13  cm  cystic 
04  Kurokawa [20]  43  F  left  22×15×10 cm  solid 
05  Ishizuka [21]  59  M  not described  30×28×12 cm  cystic 
06  Kawakami [22]  67  M  right  not described  cystic 
07  Jennings [23]  32  F  left  14×11 cm  cystic 
08  Kato [24]  66  M  left  not described  solid 
09  Gutierrez [25]  30  F  both  18 cm  both 
10  Gramlich [26]  28  F  right  30×20×14 cm  both 
11 Alanen  [27]  20  F  left  6×8  cm  both 
12  Ito [28]  43  F  both  16×16×7.7 cm  cystic 
13  Urabe [29]  39  F  left  1.2 cm  solid 
14  Drachenberg [30]  69  F  left  26×20×11.5 cm  both 
15  Wada [31]  62  M  left  6×6×4.5 cm  solid 
16  Chau [10]  53  M  right  20×14×10 cm  cystic 
17  Megremis [32]  56  F  both  7.5 cm  cystic 
18  Chung [33]  57  F  left  6×4×3.5 cm  solid 
19  Papastratis [34]  21  F  right  17×10 cm  cystic 
20  Cook [2]  46  F  right  6×4×5 cm  cystic 
21  Cook [2]  66  F  right  5×4×2 cm  cystic 
22  Cook [2]  63  F  left  11×16×24 cm  solid 
23  Brkic [35]  38  M  right  8×5 cm  solid 
24 Kim  [36]  0– M  right  5  cm  both 
25  Yesim [8]  54  F  left  2.5×2.5×1.5 cm  cystic 
26  Yesim [8]  51  F  right  6×7×8 cm  cystic 
27  Ayadi-Kaddour [37]  21  F  left  11×5 cm  cystic 
28  Hernandez [5]  51  M  right  19×13 cm  solid 
29  Li [6]  33  F  both  not described  angiosarcoma 
30  Mori [7]  36  F  right  20×15×10 cm  cystic 
31  Current case  53  F  both  9×9×7.5 cm  both 
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Table 2. Radiographic appearance of MHL [11–13] 
Imaging modality    Radiographic appearance 
Ultrasound    Anechoic, multilobular mass with thin septations. 
Computed tomography   Appearance ranges from a multilocular cystic mass with solid septa to 
multiple small cysts in a solid mass. Contrast administration enhances the 
solid component without a change in the cystic portion. 
Magnetic resonance  
imaging 
  The cystic component will show low signal intensity on T1-weighted images 
and high intensity on T2-weighted images. Solid component will depict low 
intensity on T1-weighted images due to fibrosis. 
Angiography    Cystic masses appear completely avascular due to displacement of major 
vessels. Predominantly solid lesions are hypovascular with small tumor vessels 
correlating to septa vascularization surrounding scattered cystic regions.  
 
 
 
 
Fig. 1. Noncontrast CT scan from February 2007 demonstrating a 5.3 cm septate hypodense cystic 
lesion in the right lobe of the liver. 
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Fig. 2. Repeat abdominal CT scan in July 2008 revealing an enlarging heterogeneous, progressively 
enhancing solid and cystic mass in the anterior segment of the right hepatic lobe (Couinaud’s 
segments V and VIII). The mass measures 8.9 × 8.7 × 7.5 cm and displaces hepatic and portal veins. 
 
 
 
Fig. 3. Microscopic image. The liver mass consists of rare benign dilated bile ducts corresponding to the 
cystic areas. The cytologically benign stroma is extremely myxoid with spindle cells. The mass had a 
fibrous capsule with bile duct proliferation at the edge with a sharp transition into the normal liver 
tissue (arrow), diagnostic of mesenchymal hamartoma. 10×, HE stain. 
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